Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

evaluation of immunomodulatory cytokines by ELISA kits on peripheral blood samples

evaluation of somatic mutations commonly associated with myeloid neoplasm and immunodeficiencies by next generation sequencing on peripheral blood samples

evaluation of fecal microbiome on fecal samples

evaluation of recombinant erythropoietin use, safety and efficacy in patients with autoimmune hemolytic anemia according to clinical practice

evaluation of cytokine levels, molecular profile and bone marrow microenvironment by single cell analysis in patients treated with luspatercept according to clinical practice

evaluation of TPO-RA use, safety and efficacy in patients with ITP according to clinical practice

evaluation of G-CSF use, safety and efficacy in patients with CIN/AIN according to clinical practice